Animal Modeling, Photonics, and Antidote Efficacy Core

动物建模、光子学和解毒功效核心

基本信息

  • 批准号:
    9981041
  • 负责人:
  • 金额:
    $ 80.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Animal Modeling, Photonics, and Efficacy Evaluation Core (AEC) Abstract The Animal Modeling, Photonics and Efficacy Evaluation Core consists of two core photonics based diagnostic technologies and 2 non-rodent species of established CN poisoning: highly monitored mid-size animal (rabbit) (UC Irvine) and large animal (pig) models (University of Colorado Denver). The core provides the capabilities for advanced in-vivo animal candidate antidote diagnostics, efficacy testing, and capabilities for real time quantitative determination of chemical induced injury development, extent, and response to therapy. The Core supports advanced mammalian testing of the promising antidote candidates identified in projects 1, 2, and 3. This integrated core has the capability to rapidly advance testing of such candidate agents in pre-clinical evaluation, as well as to provide feedback iteration to the earlier phase projects and to the Pharmaceutical Sciences Core for drug design enhancement, and to provide samples to the Metabolic Phenotyping and Pharmacokinetics Core (MPPC) to promote our mechanistic understanding of the consequences of CN poisoning. The Core photonics based technologies include diffuse optical spectroscopy and continuous wave near infrared spectroscopy for assessment of effects of the metabolic poison cyanide, and monitoring of tissue oxygenation and cytochrome C oxidase redox states in the rabbit and swine models, and real-time micro-sensors for continuous tissue lactate monitoring in animals with metabolic poison exposures. The core will also provide a state-of-the-art rabbit testing facility and established lethal and sub-lethal models for cyanide antidote development supporting all projects. Advanced technology capabilities will be extended to the U. of Colorado as part of the Core deliverables, and will function there in the large animal (pig) model in addition to their ongoing availability in the rabbit testing facility and animal operating rooms at UC Irvine Beckman Laser Institute. As shown in our prior chemical defense research, these core technologies enable more accurate, precise, and noninvasive determination of injury and treatment effectiveness, dramatically accelerating antidote development and reducing animal numbers required for definitive results and successful translation of antidote compounds to therapeutic use.
动物建模、光子学和有效性评价核心(AEC) 摘要 动物建模、光子学和功效评估核心由两个部分组成 基于核心光子学的诊断技术和2种已建立的非啮齿动物物种 氯化萘中毒:高度监测中型动物(兔)(UC Irvine)和大型动物 (pig)模型(科罗拉多丹佛大学)。核心提供了以下功能 先进的体内动物候选解毒剂诊断、功效测试和能力 用于真实的实时定量测定化学诱导损伤的发展,程度, 和对治疗的反应核心支持先进的哺乳动物测试, 在项目1、2和3中确定了有希望的候选解毒剂。这一综合核心具有 在临床前阶段快速推进此类候选药物测试的能力 评估,以及为早期阶段的项目提供反馈迭代, 药物设计增强的药物科学核心,并提供 代谢表型和药代动力学核心(MPPC),以促进 我们对氯化萘中毒后果的机械理解。 基于核心光子学的技术包括漫射光谱学和 连续波近红外光谱法用于评估代谢产物的影响 氰化物中毒,并监测组织氧合和细胞色素C氧化酶氧化还原 状态的兔子和猪的模型,和实时微传感器的连续组织 代谢性毒物暴露动物的乳酸盐监测。核心还将 提供最先进的兔子测试设施,并建立了致命和亚致命的 为所有项目提供氰化物解毒剂开发模型。先进技术 能力将扩展到美国。作为核心交付成果的一部分, 将在大型动物(猪)模型中发挥作用, 在UC Irvine Beckman Laser的家兔试验机构和动物手术室中, 院正如我们先前的化学防御研究所显示的那样,这些核心技术 能够更准确、精确和无创地确定损伤和治疗 有效性,大大加快解毒剂的开发, 确定结果和成功转化解毒剂化合物所需的数量 用于治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Calum A. MacRae其他文献

EN-499638-002 PHARMACOLOGIC RESCUE OF LOSS-OF-FUNCTION CARDIAC SODIUM CHANNELOPATHIES
EN-499638-002 功能性丧失型心脏钠通道病的药理学拯救
  • DOI:
    10.1016/j.hrthm.2025.03.029
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    David Y. Chiang;Rachelle Victorio;Ashley Lin;John Oh;David Zhao;Franki Vetrano-Olsen;Wandi Zhu;Calum A. MacRae
  • 通讯作者:
    Calum A. MacRae
The Deep Genome Project
  • DOI:
    10.1186/s13059-020-1931-9
  • 发表时间:
    2020-02-03
  • 期刊:
  • 影响因子:
    9.400
  • 作者:
    K. C. Kent Lloyd;David J. Adams;Gareth Baynam;Arthur L. Beaudet;Fatima Bosch;Kym M. Boycott;Robert E. Braun;Mark Caulfield;Ronald Cohn;Mary E. Dickinson;Michael S. Dobbie;Ann M. Flenniken;Paul Flicek;Sanjeev Galande;Xiang Gao;Anne Grobler;Jason D. Heaney;Yann Herault;Martin Hrabě de Angelis;James R. Lupski;Stanislas Lyonnet;Ann-Marie Mallon;Fabio Mammano;Calum A. MacRae;Roderick McInnes;Colin McKerlie;Terrence F. Meehan;Stephen A. Murray;Lauryl M. J. Nutter;Yuichi Obata;Helen Parkinson;Michael S. Pepper;Radislav Sedlacek;Je Kyung Seong;Toshihiko Shiroishi;Damian Smedley;Glauco Tocchini-Valentini;David Valle;Chi-Kuang Leo Wang;Sara Wells;Jacqueline White;Wolfgang Wurst;Ying Xu;Steve D. M. Brown
  • 通讯作者:
    Steve D. M. Brown
AN UNDERSERVED COMMUNITY-BASED HYPERTENSION CONTROL USING HEALTH WORKERS OUTREACH AND ALGORITHMIC SOFTWARE-DRIVEN BLOOD PRESSURE MANAGEMENT
  • DOI:
    10.1016/s0735-1097(23)02101-0
  • 发表时间:
    2023-03-07
  • 期刊:
  • 影响因子:
  • 作者:
    Rahul Deo;Ogechi Nwoko;Sandra Bruce Nichols;Esha Price;Wanda Baker;Rahul Patel;Calum A. MacRae;Jaime E. Murillo
  • 通讯作者:
    Jaime E. Murillo
Stx4 is required to regulate cardiomyocyte Casup2+/sup handling during vertebrate cardiac development
在脊椎动物心脏发育过程中,Stx4 是调节心肌细胞钙离子处理所必需的。
  • DOI:
    10.1016/j.xhgg.2022.100115
  • 发表时间:
    2022-07-14
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Eliyahu Perl;Padmapriyadarshini Ravisankar;Manu E. Beerens;Lejla Mulahasanovic;Kelly Smallwood;Marion Bermúdez Sasso;Carina Wenzel;Thomas D. Ryan;Matej Komár;Kevin E. Bove;Calum A. MacRae;K. Nicole Weaver;Carlos E. Prada;Joshua S. Waxman
  • 通讯作者:
    Joshua S. Waxman
Developmental Inotropic Sensitivity to Isoproterenol in Developing Zebrafish Hearts In Vivo
  • DOI:
    10.1016/j.cardfail.2009.06.369
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hannah L. Semigran;Calum A. MacRae;Jordan T. Shin
  • 通讯作者:
    Jordan T. Shin

Calum A. MacRae的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Calum A. MacRae', 18)}}的其他基金

Animal Modeling, Photonics, and Antidote Efficacy Core
动物建模、光子学和解毒功效核心
  • 批准号:
    10426367
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Advancing Novel Cyanide Countermeasures
推进新型氰化物对策
  • 批准号:
    10426362
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Animal Modeling, Photonics, and Antidote Efficacy Core
动物建模、光子学和解毒功效核心
  • 批准号:
    10671666
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Administrative Core for Center Management and Operations
中心管理和运营的行政核心
  • 批准号:
    10671659
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Advancing Novel Cyanide Countermeasures
推进新型氰化物对策
  • 批准号:
    10671658
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Optimizing hexacholorplatinate for clinical deployment
优化六氯铂以进行临床部署
  • 批准号:
    10241500
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Optimizing hexacholorplatinate for clinical deployment
优化六氯铂以进行临床部署
  • 批准号:
    9981042
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Animal Modeling, Photonics, and Antidote Efficacy Core
动物建模、光子学和解毒功效核心
  • 批准号:
    10241498
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Advancing novel cyanide countermeasures
推进新型氰化物对策
  • 批准号:
    10241493
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:
Administrative Core for Center Management and Operations
中心管理和运营的行政核心
  • 批准号:
    10426363
  • 财政年份:
    2019
  • 资助金额:
    $ 80.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了